VALLEY COTTAGE, New York, March 31, 2017 /PRNewswire/ --
Zoetis Inc. will continue to account for a leading share of the US$ 2.26 Bn (2016) global companion animal vaccine market. The pharmaceutical company accounted for over 46% share of the global market in 2015, and it is expected to maintain its numero uno position during the forecast period 2016-2026. Merck & Co., Inc. and Merial, will remain the other key players in this market.
(Logo: http://photos.prnewswire.com/prnh/20161020/430874LOGO )
The key factors that will fuel demand for companion animal vaccines include,
According to Future Market Insights' research, lack of information on emerging virulent veterinary diseases, and decline sales revenues through veterinarians can stifle demand for companion animal vaccines during the forecast period. The longstanding challenges with correctly identifying and understanding antigen/immunogenic structures can also negatively impact the growth of the market.
By product type, nearly US$ 764 Mn worth of attenuated live vaccines were sold globally in 2016. This segment is projected to grow at a CAGR of 7.3% during the forecast period 2016-2026.
Distribution Channel Analysis: Veterinary Clinics will Remain the Preferred Distribution Channel
Veterinary clinics continue to be the preferred distribution channel for pharma companies, followed by veterinary hospitals. These two point of care centres witness substantial footfall of pet owners all year round, and drug companies continuously focus on increasing sales through these channels. In 2016, these two distribution channels collectively accounted for nearly 75% revenue share of the market. By the end of forecast period, the status quo is expected to remain unchanged. Retail pharmacies, which held 20% share of the market in 2016, will grow at the highest CAGR during the forecast period.
Preview Analysis on Companion Animal Vaccines Market Segmentation By Product Type - Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines and Recombinant Vaccines; By Species Type - Canine, Avian, Feline; By Distribution Channel - Companion Animal Clinics, Companion Animal Hospitals and Companion Animal Research Institutes: http://www.futuremarketinsights.com/reports/companion-animal-vaccines-market
North America Largest Market for Companion Animal Vaccines
The U.S. continues to be a leading market for companion animal vaccines. High level of awareness among pet owners, combined with easy availability of pet healthcare have resulted into the growth of the market in the U.S. On account of strong demand in the U.S., North America will continue to be the largest market globally.
The North America companion animals market was valued at nearly US$ 676 in 2016. It is projected to increase at 6.9% CAGR through 2026, reaching over US$ 1.3 Bn in revenues. Western Europe, the second-largest market for companion animal vaccines is projected to grow at 7.1% CAGR through 2026.
Speak with Analyst for any Report Related Queries: http://www.futuremarketinsights.com/askus/rep-gb-1427
Overall, Future Market Insights maintains a positive outlook on the global companion animal vaccines market, projecting it to grow at 6.8% CAGR during the forecast period 2016-2026.
More from FMI's Cutting-edge Intelligence:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.
Browse More Healthcare, Pharmaceuticals and Medical devices Market Insights
Contact Us 616 Corporate Way, Suite 2-9018, Valley Cottage, NY 10989, United States T: +1-347-918-3531 F: +1-845-579-5705 T (UK): + 44 (0) 20 7692 8790 Sales: [email protected] Press Office: [email protected]
Website: http://www.futuremarketinsights.com
SOURCE Future Market Insights
Advertisement
Zoetis Inc. will continue to account for a leading share of the US$ 2.26 Bn (2016) global companion animal vaccine market. The pharmaceutical company accounted for over 46% share of the global market in 2015, and it is expected to maintain its numero uno position during the forecast period 2016-2026. Merck & Co., Inc. and Merial, will remain the other key players in this market.
Advertisement
(Logo: http://photos.prnewswire.com/prnh/20161020/430874LOGO )
The key factors that will fuel demand for companion animal vaccines include,
- Increasing trend of pet humanisation in developing countries
- Adoption of pet vaccination programmes, such as 'herd immunity' and 'One Health'
- Increasing emphasis on preventing and detecting avian flu
- Rising pet insurance rates in the U.S. and other developed countries
- Awareness on the benefits of preventive healthcare over reactive healthcare
- Collaboration among leading pharmaceutical manufacturers for research and development.
According to Future Market Insights' research, lack of information on emerging virulent veterinary diseases, and decline sales revenues through veterinarians can stifle demand for companion animal vaccines during the forecast period. The longstanding challenges with correctly identifying and understanding antigen/immunogenic structures can also negatively impact the growth of the market.
By product type, nearly US$ 764 Mn worth of attenuated live vaccines were sold globally in 2016. This segment is projected to grow at a CAGR of 7.3% during the forecast period 2016-2026.
Distribution Channel Analysis: Veterinary Clinics will Remain the Preferred Distribution Channel
Veterinary clinics continue to be the preferred distribution channel for pharma companies, followed by veterinary hospitals. These two point of care centres witness substantial footfall of pet owners all year round, and drug companies continuously focus on increasing sales through these channels. In 2016, these two distribution channels collectively accounted for nearly 75% revenue share of the market. By the end of forecast period, the status quo is expected to remain unchanged. Retail pharmacies, which held 20% share of the market in 2016, will grow at the highest CAGR during the forecast period.
Preview Analysis on Companion Animal Vaccines Market Segmentation By Product Type - Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines and Recombinant Vaccines; By Species Type - Canine, Avian, Feline; By Distribution Channel - Companion Animal Clinics, Companion Animal Hospitals and Companion Animal Research Institutes: http://www.futuremarketinsights.com/reports/companion-animal-vaccines-market
North America Largest Market for Companion Animal Vaccines
The U.S. continues to be a leading market for companion animal vaccines. High level of awareness among pet owners, combined with easy availability of pet healthcare have resulted into the growth of the market in the U.S. On account of strong demand in the U.S., North America will continue to be the largest market globally.
The North America companion animals market was valued at nearly US$ 676 in 2016. It is projected to increase at 6.9% CAGR through 2026, reaching over US$ 1.3 Bn in revenues. Western Europe, the second-largest market for companion animal vaccines is projected to grow at 7.1% CAGR through 2026.
Speak with Analyst for any Report Related Queries: http://www.futuremarketinsights.com/askus/rep-gb-1427
Overall, Future Market Insights maintains a positive outlook on the global companion animal vaccines market, projecting it to grow at 6.8% CAGR during the forecast period 2016-2026.
More from FMI's Cutting-edge Intelligence:
- Radio Frequency Beauty Equipment Market Segmentation By Product Type - Table Top, Trolley Mounted and Portable; By Technology - Mono-Polar Frequency, Bio-Polar Radio Frequency, Multi-Polar Radio Frequency and Fractional Radio Frequency; By Application - Skin Treatment (Skin Reconstruction, Scar Removal and Non-Surgical Skin Tightening), Body Contouring (Liposuction, Cellulite Reduction and Non-Surgical Fat Reduction) and Hair Removal; By End User - Beauty Care Centre and Home Care Settings: http://www.futuremarketinsights.com/reports/radio-frequency-beauty-equipment-market
- Hypercalcemia Treatment Market Segmentation By Product Type - Bisphosphonates, Calcitonin, Glucocorticoids, Denosumab, Calcimimetics; By End-User - Hospitals, Clinics, and Independent Pharmacy and Drug Stores: http://www.futuremarketinsights.com/reports/hypercalcemia-treatment-market
- Central Venous Catheter Market Segmentation By Product Type - Tunnelled Catheters and Non-Tunnelled Catheters, By Property - Antimicrobial Catheters and Non Antimicrobial Catheters, By Design - Single Lumen, Double Lumen and Multi Lumen, By Composition - Polyurethane, Polyurethane / Poly Carbonate and Silicone, By End Use - Hospitals, Ambulatory Surgical Centres, Specialty Clinics and Others: http://www.futuremarketinsights.com/reports/central-venous-catheter-market
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.
Browse More Healthcare, Pharmaceuticals and Medical devices Market Insights
Contact Us 616 Corporate Way, Suite 2-9018, Valley Cottage, NY 10989, United States T: +1-347-918-3531 F: +1-845-579-5705 T (UK): + 44 (0) 20 7692 8790 Sales: [email protected] Press Office: [email protected]
Website: http://www.futuremarketinsights.com
SOURCE Future Market Insights
